M. Holder

发表

Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis

I. Maclennan, Yong‐jun Liu, J. Cairns, 1991, European journal of immunology.

Low level light therapy (LLLT) for the treatment and management of dental and oral diseases

M. Holder, P. Cooper, M. Milward, 2014 .

Effects of Red Light-emitting Diode Irradiation on Dental Pulp Cells

M. Holder, P. Cooper, M. Milward, 2012, Journal of dental research.

Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells.

A. Challa, M. Holder, J. Gordon, 2007, Biochemical and biophysical research communications.

Improved access to CD20 following B cell receptor cross-linking at Burkitt's lymphoma cell surfaces.

M. Holder, J. Gordon, J. Deans, 2004, Leukemia research.

Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl‐2 induction

I. Maclennan, M. Holder, J. Gordon, 1993, European journal of immunology.

Inflammation and regeneration in the dentin-pulp complex: a double-edged sword.

M. Holder, P. Cooper, Anthony J. Smith, 2014, Journal of endodontics.

The dark art of light measurement: accurate radiometry for low-level light therapy

M. Holder, P. Cooper, M. Milward, 2016, Lasers in Medical Science.

Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.

C. Bunce, M. Drayson, J. Gordon, 2003, Blood.

Close encounters of the monoamine kind: immune cells betray their nervous disposition

N. Barnes, M. Holder, J. Gordon, 2005, Immunology.

Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death

M. Dyer, A. Challa, N. Barnes, 2012, Investigational New Drugs.

The extrafollicular‐to‐follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40

M. Holder, J. Gordon, L. Roberts, 1999, European journal of immunology.

A subset of anti‐CD21 antibodies promote the rescue of germinal center B cells from apoptosis

M. Holder, J. Bonnefoy, J. Gordon, 1993, European journal of immunology.

Neutrophil Extracellular Traps Exert Potential Cytotoxic and Proinflammatory Effects in the Dental Pulp

M. Holder, E. Couve, P. Cooper, 2019, Journal of Endodontics.

Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation

N. Barnes, M. Holder, J. Gordon, 2008, Journal of Neuroimmunology.

Engagement of CD20 suppresses apoptosis in germinal center B cells

M. Holder, J. Gordon, M. Finney, 1995, European journal of immunology.

Growth factor requirements for the stimulation of germinal center B cells: evidence for an IL-2-dependent pathway of development.

I. Maclennan, Y. Liu, M. Holder, 1991, International immunology.

Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor‐β, but not cyclosporin A or anti‐CD19, block surface immunoglobulin‐mediated rescue from apoptosis

M. Holder, J. Gordon, K. Knox, 1992, European journal of immunology.

Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin’s lymphoma

M. Dyer, N. Barnes, M. Holder, 2006, Proceedings of the National Academy of Sciences.

CD5‐positive and CD5‐negative human B cells converge to an indistinguishable population on signalling through B‐cell receptors and CD40

A. Challa, J. Pound, M. Holder, 2000, Immunology.

biopsylike Burkitt lymphoma cells Population depletion activates autonomous CD154-dependent survival in

A. Challa, J. Gordon, L. Young, 2013 .

Population depletion activates autonomous CD154-dependent survival in biopsylike Burkitt lymphoma cells.

A. Challa, J. Gordon, A. Eliopoulos, 2002, Blood.

Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells.

A. Challa, J. Pound, R. Armitage, 1999, International immunology.

The serotonin transporter (SLC6A4) is present in B‐cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics

R. Blakely, M. Dyer, C. Bunce, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Stimulation of tyrosine phosphorylation without inositol lipid hydrolysis in human B lymphocytes on engaging CD72

M. Holder, J. Gordon, M. Finney, 1993, FEBS Letters.

IL-2 expands and maintains IgM plasmablasts from a CD5+ subset contained within the germinal centre cell-enriched (surface IgD-/CD39- buoyant) fraction of human tonsil.

I. Maclennan, M. Holder, J. Gordon, 1993, International immunology.

Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind annexin V in response to B-cell receptor engagement: a cautionary tale.

N. Barnes, M. Holder, J. Gordon, 2006, Leukemia research.

Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens.

J. Pound, M. Holder, J. Gordon, 1994, Cellular and molecular biology.